479 related articles for article (PubMed ID: 29431201)
1. The in-hospital burden of hidradenitis suppurativa in patients with inflammatory bowel disease: a decade nationwide analysis from 2004 to 2014.
Ramos-Rodriguez AJ; Timerman D; Khan A; Bonomo L; Hunjan MK; Lemor A
Int J Dermatol; 2018 May; 57(5):547-552. PubMed ID: 29431201
[TBL] [Abstract][Full Text] [Related]
2. Increased utilization of emergency department and inpatient care by patients with hidradenitis suppurativa.
Khalsa A; Liu G; Kirby JS
J Am Acad Dermatol; 2015 Oct; 73(4):609-14. PubMed ID: 26190241
[TBL] [Abstract][Full Text] [Related]
3. Hidradenitis Suppurativa in Patients With Inflammatory Bowel Disease: A Population-Based Cohort Study in Olmsted County, Minnesota.
Yadav S; Singh S; Edakkanambeth Varayil J; Harmsen WS; Zinsmeister AR; Tremaine WJ; Davis MD; Wetter DA; Colombel JF; Loftus EV
Clin Gastroenterol Hepatol; 2016 Jan; 14(1):65-70. PubMed ID: 25952308
[TBL] [Abstract][Full Text] [Related]
4. Health care utilization patterns and costs for patients with hidradenitis suppurativa.
Kirby JS; Miller JJ; Adams DR; Leslie D
JAMA Dermatol; 2014 Sep; 150(9):937-44. PubMed ID: 24908260
[TBL] [Abstract][Full Text] [Related]
5. Association between hidradenitis suppurativa and hospitalization for psychiatric disorders: a cross-sectional analysis of the National Inpatient Sample.
Patel KR; Rastogi S; Singam V; Lee HH; Amin AZ; Silverberg JI
Br J Dermatol; 2019 Aug; 181(2):275-281. PubMed ID: 30422314
[TBL] [Abstract][Full Text] [Related]
6. Impact of Bariatric Surgery on Outcomes of Patients with Inflammatory Bowel Disease: a Nationwide Inpatient Sample Analysis, 2004-2014.
Sharma P; McCarty TR; Njei B
Obes Surg; 2018 Apr; 28(4):1015-1024. PubMed ID: 29047047
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors for Hidradenitis Suppurativa in Patients with Inflammatory Bowel Disease.
Lukach AJ; Saul MI; Ferris LK; Swoger JM
Dig Dis Sci; 2018 Mar; 63(3):755-760. PubMed ID: 29357084
[TBL] [Abstract][Full Text] [Related]
8. Hospitalisations with Hidradenitis Suppurativa: An Increasing Problem That Deserves Closer Attention.
Santos JV; Lisboa C; Lanna C; Costa-Pereira A; Freitas A
Dermatology; 2016; 232(5):613-618. PubMed ID: 27684441
[TBL] [Abstract][Full Text] [Related]
9. Infections and Cardiovascular Complications are Common Causes for Hospitalization in Older Patients with Inflammatory Bowel Diseases.
Nguyen NH; Ohno-Machado L; Sandborn WJ; Singh S
Inflamm Bowel Dis; 2018 Mar; 24(4):916-923. PubMed ID: 29562273
[TBL] [Abstract][Full Text] [Related]
10. Hidradenitis suppurativa and inflammatory bowel disease in a nested case-control study.
Neri B; Mossa M; Salvatori S; Appolloni V; Pensa C; Lambiase S; Lolli E; Calabrese E; Monteleone G; Bianchi L; Campione E; Biancone L
Dig Liver Dis; 2023 Apr; 55(4):490-495. PubMed ID: 36371384
[TBL] [Abstract][Full Text] [Related]
11. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis.
Shlyankevich J; Chen AJ; Kim GE; Kimball AB
J Am Acad Dermatol; 2014 Dec; 71(6):1144-50. PubMed ID: 25440440
[TBL] [Abstract][Full Text] [Related]
12. High burden of hospital resource utilization in patients with hidradenitis suppurativa in England: a retrospective cohort study using hospital episode statistics.
Desai N; Shah P
Br J Dermatol; 2017 Apr; 176(4):1048-1055. PubMed ID: 27534703
[TBL] [Abstract][Full Text] [Related]
13. Identification of Clinical and Genetic Parameters Associated with Hidradenitis Suppurativa in Inflammatory Bowel Disease.
Janse IC; Koldijk MJ; Spekhorst LM; Vila AV; Weersma RK; Dijkstra G; Horváth B
Inflamm Bowel Dis; 2016 Jan; 22(1):106-13. PubMed ID: 26422515
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of type 2 diabetes mellitus among patients with hidradenitis suppurativa in the United States.
Garg A; Birabaharan M; Strunk A
J Am Acad Dermatol; 2018 Jul; 79(1):71-76. PubMed ID: 29339240
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory bowel disease is associated with hidradenitis suppurativa: Results from a multicenter cross-sectional study.
Deckers IE; Benhadou F; Koldijk MJ; Del Marmol V; Horváth B; Boer J; van der Zee HH; Prens EP
J Am Acad Dermatol; 2017 Jan; 76(1):49-53. PubMed ID: 27793450
[TBL] [Abstract][Full Text] [Related]
16. Causal association between inflammatory bowel disease and hidradenitis suppurativa: A two-sample bidirectional Mendelian randomization study.
Bao B; Zhu C; Shi J; Lu C
Front Immunol; 2023; 14():1071616. PubMed ID: 36776852
[TBL] [Abstract][Full Text] [Related]
17. Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort Study.
Garg A; Geissbühler Y; Houchen E; Choudhary N; Arora D; Vellanki V; Srivastava A; Priyanka ; Darcy J; Richardson C; Kimball AB
Am J Clin Dermatol; 2023 Nov; 24(6):977-990. PubMed ID: 37378875
[TBL] [Abstract][Full Text] [Related]
18. Recommendations for the management of comorbidity in hidradenitis suppurativa.
Dauden E; Lazaro P; Aguilar MD; Blasco AJ; Suarez C; Marin I; Queiro R; Bassas-Vila J; Martorell A; García-Campayo J
J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):129-144. PubMed ID: 28796920
[TBL] [Abstract][Full Text] [Related]
19. Descriptive epidemiology of children hospitalized for inflammatory bowel disease in Japan: Inpatient database analysis.
Takeuchi M; Tomomasa T; Yasunaga H; Horiguchi H; Fushimi K
Pediatr Int; 2015 Jun; 57(3):443-8. PubMed ID: 25442802
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of inflammatory bowel disease among pediatric patients with hidradenitis suppurativa and the potential role of screening with fecal calprotectin.
Lloyd-McLennan AM; Ali S; Kittler NW
Pediatr Dermatol; 2021 Jan; 38(1):98-102. PubMed ID: 33099810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
